Calithera biosciences, inc. (CALA)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Cash Flows Used in Operating Activities
Net loss

-24,446

-21,728

-20,293

-24,152

-23,687

-19,499

-18,849

-3,075

-13,206

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-5,587

-

-8,544

-10,358

-9,582

-8,068

-8,900

-7,818

-7,858

-6,833

-5,239

-5,491

-4,149

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation

105

113

116

125

125

130

127

124

124

111

90

84

80

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of premiums on investments

85

167

286

234

210

148

129

31

-36

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

70

67

85

84

92

119

109

104

102

82

73

Amortization of premiums on investments

-

-

-

-

-

-

-

-

-

-

-

152

79

-

142

168

175

178

156

110

2

-

-

-

-

Stock-based compensation

1,993

1,458

1,530

1,795

1,683

1,820

1,816

1,920

1,881

1,568

1,465

1,354

1,149

1,063

1,073

1,087

1,027

1,012

876

789

595

314

164

133

78

Loss on disposal of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-1

0

8

-

-

-

-

Non-cash lease expense

362

354

346

337

329

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Receivables from collaborations

494

-1,230

-28

-773

516

188

-702

687

682

-1,035

-126

-11,247

13,550

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

-231

461

-34

-160

-241

549

67

-1,480

234

-1,485

2,364

48

25

164

-333

-397

-221

771

96

-28

-166

496

-100

825

323

Other assets

278

-81

77

-348

63

-276

207

236

174

-530

433

196

-161

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

-1,318

1,350

-546

-353

365

738

-521

-1,134

1,092

-93

755

-168

180

-731

-181

396

488

-3

-358

364

-134

-94

-99

712

24

Accrued liabilities

-2,682

-237

-160

1,512

1,461

3,561

569

-771

1,366

1,789

2,158

1,080

-149

544

127

268

-14

-2,047

1,872

445

-466

1,093

117

1,139

-291

Lease liability

403

388

368

361

352

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

0

0

-17,065

-5,189

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-7,254

52,807

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent, non-current

-

-

-

-

-

-29

-3

35

34

347

98

105

106

-

-

-

-6

-

-35

-35

-35

11

17

278

66

Net cash used in operating activities

-27,015

-18,395

-19,676

-20,050

-20,624

-13,888

-16,562

-19,440

-14,952

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash Flows (Used in) Provided by Investing Activities
Net cash provided by (used in) operating activities

-

-

-

-

-

-

-

-

-

-

-

-

35,251

-

-7,004

-7,642

-7,606

-9,914

-6,392

-5,998

-7,629

-4,471

-5,657

-4,581

-4,522

Purchases of investments

57,059

25,247

76,950

36,926

14,104

28,815

5,943

24,517

16,832

20,293

28,089

52,253

94,015

8,807

11,751

11,574

12,486

20,253

7,289

61,151

20,406

-

-

-

-

Proceeds from sale and maturity of investments

56,458

40,400

41,750

37,200

23,100

24,250

22,200

44,644

38,026

39,499

21,040

19,809

17,100

12,184

19,970

14,495

22,075

-

-

-

-

-

-

-

-

Purchases of property and equipment

13

-

-

-

-

30

122

36

26

547

455

177

50

164

26

46

165

101

55

221

64

70

304

122

60

Net cash (used in) provided by investing activities

-614

15,154

-35,208

274

8,996

-4,595

16,135

20,091

21,168

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash Flows Provided by Financing Activities
Net cash provided by (used in) investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-76,965

-

8,193

2,875

9,424

7,288

3,242

-56,836

-20,470

-70

-304

-52

-60

Proceeds from issuance of common stock upon public offering, net

-

-

-

-

-

-

-

-

-

-

0

-287

75,673

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock under stock purchase agreement, net

-

-

-

-

-

-

-

-

-

0

0

0

7,914

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock through an at-the-market offering, net

7,397

41,403

23

1,354

1,146

-

-

-

-

1,408

0

-11

36,918

4,320

2,990

-265

4,236

-

-

-

-

-

-

-

-

Proceeds from stock option exercises

262

-

-

-

8

-

-

-

150

-

-

-

74

-

-

-

7

-

-

-

7

-

-

-

17

Net cash provided by financing activities

7,659

42,017

-247

55,984

1,154

8,406

5,692

378

150

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

120,579

-

3,085

-73

4,243

300

262

276

7

71,658

13,063

3,128

17

Net decrease in cash, cash equivalents, and restricted cash

-19,970

38,776

-55,131

36,208

-10,474

-10,077

5,265

1,029

6,366

9,064

-18,586

-31,075

78,865

-

-

-

-

-

-

-

-

-

-

-

-

Supplemental Disclosure of Non-Cash Financing Information:
Net increase (decrease) in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,274

-4,840

6,061

-2,326

-2,888

-62,558

-28,092

67,117

7,102

-1,505

-4,565

Supplemental Disclosure of Non-Cash Activities:
Unpaid amounts related to stock issuance and deferred financing costs

74

-

-

255

29

-

-

-31

58

-

-

-

298

-

-

-

-

-

-

-

-

-

-

-

-

Unpaid amounts related to property and equipment purchases

-

-

-

-

-

-

-

-

-

-

-

-

45

-

-

-

-

-

-

-

-

-

-

-

-